$73.11
1.96% yesterday
Nasdaq, Dec 01, 10:05 pm CET
ISIN
US8064071025
Symbol
HSIC

Henry Schein Stock price

$73.11
+8.47 13.10% 1M
+3.55 5.10% 6M
+3.91 5.65% YTD
-3.39 4.43% 1Y
-9.84 11.86% 3Y
+8.20 12.63% 5Y
+10.74 17.22% 10Y
+56.16 331.27% 20Y
Nasdaq, Closing price Mon, Dec 01 2025
-1.46 1.96%

New AI Insights on Henry Schein Insights AI Insights on Henry Schein

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$8.8b
Enterprise Value
$11.7b
Net debt
$3.0b
Cash
$136.0m
Shares outstanding
118.6m
Valuation (TTM | estimate)
P/E
23.1 | 15.2
P/S
0.7 | 0.7
EV/Sales
0.9 | 0.9
EV/FCF
33.0
P/B
2.6
Financial Health
Equity Ratio
33.2%
Return on Equity
11.5%
ROCE
9.7%
ROIC
6.1%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$12.9b | $13.3b
EBITDA
$1.0b | $1.1b
EBIT
$769.0m | $978.7m
Net Income
$391.0m | $583.2m
Free Cash Flow
$356.0m
Growth (TTM | estimate)
Revenue
3.5% | 4.6%
EBITDA
20.1% | 9.6%
EBIT
26.5% | 32.8%
Net Income
24.5% | 49.5%
Free Cash Flow
-9.0%
Margin (TTM | estimate)
Gross
31.2%
EBITDA
7.9% | 8.4%
EBIT
5.9%
Net
3.0% | 4.4%
Free Cash Flow
2.8%
More
EPS
$3.2
FCF per Share
$3.0
Short interest
7.0%
Employees
25k
Rev per Employee
$510.0k
Show more

Is Henry Schein a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Henry Schein Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Henry Schein forecast:

10x Buy
43%
11x Hold
48%
2x Sell
9%

Analyst Opinions

23 Analysts have issued a Henry Schein forecast:

Buy
43%
Hold
48%
Sell
9%

Financial data from Henry Schein

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
12,938 12,938
4% 4%
100%
- Direct Costs 8,903 8,903
4% 4%
69%
4,035 4,035
2% 2%
31%
- Selling and Administrative Expenses 3,009 3,009
3% 3%
23%
- Research and Development Expense - -
-
-
1,026 1,026
20% 20%
8%
- Depreciation and Amortization 257 257
4% 4%
2%
EBIT (Operating Income) EBIT 769 769
26% 26%
6%
Net Profit 391 391
25% 25%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Henry Schein directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Henry Schein Stock News

Neutral
Business Wire
about 7 hours ago
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the drill-free Curodont™ Repair Fluoride Plus (“Curodont”) product across all dental market segments, effective January 1, 2026. The strategic expansion broadens Henry Schein's previous exclusivity with th...
Positive
Seeking Alpha
5 days ago
Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung shares are finally starting to benefit from AI enthusiasm. Elevance's share price declined by 16%, making it our largest negative contributor.
Neutral
Business Wire
7 days ago
AMERICAN FORK, Utah--(BUSINESS WIRE)--Coming off the heels of its announcement with Amazon Web Services, Henry Schein One, the leading provider of global dental technology, today unveils natively embedded AI and automation workflows. This includes Voice Notes, which helps practices close revenue gaps through clean claims, and modernize more effectively. “Our goal isn't piecemeal AI and automati...
More Henry Schein News

Company Profile

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Head office United States
CEO Stanley Bergman
Employees 25,000
Founded 1932
Website www.henryschein.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today